Status:
COMPLETED
Comparing OTC Acne Treatment to Prescription Regimen
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
Loreal USA
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for th...
Detailed Description
There are many products on the market to treat facial acne. The medication that this study will be evaluating, Benzaclin and Retin-A have been approved by the FDA and is available by prescription, Eff...
Eligibility Criteria
Inclusion
- males and females ages 18-50, mild to moderate acne vulgaris with \> or equal to 15 inflammatory lesions, \> or equal to 20 non-inflammatory lesions, avoid excessive sun exposure or tanning beds throughout the study
Exclusion
- Participants who have another skin condition that will interfere with lesion counting or assessments
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01237821
Start Date
October 1 2010
End Date
October 1 2011
Last Update
July 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States, 17033